Costs and Expenses in USD of Regen BioPharma Inc from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Regen BioPharma Inc quarterly/annual Costs and Expenses history and change rate from Q1 2013 to Q3 2024.
  • Regen BioPharma Inc Costs and Expenses for the quarter ending 30 Sep 2024 was $146K, a 23% increase year-over-year.
  • Regen BioPharma Inc Costs and Expenses for the twelve months ending 30 Sep 2024 was $655K, a 29.1% decline year-over-year.
  • Regen BioPharma Inc annual Costs and Expenses for 2024 was $655K, a 29.1% decline from 2023.
  • Regen BioPharma Inc annual Costs and Expenses for 2023 was $924K, a 60.6% increase from 2022.
  • Regen BioPharma Inc annual Costs and Expenses for 2022 was $575K, a 54.6% increase from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Change (%)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Change (%)

Regen BioPharma Inc Quarterly Costs and Expenses (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $655K $146K +$27.3K +23% 01 Jul 2024 30 Sep 2024 8-K 29 Nov 2024
Q2 2024 $627K $167K +$22.8K +15.8% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2024
Q1 2024 $605K $160K +$22.2K +16.1% 01 Jan 2024 31 Mar 2024 10-Q 24 Apr 2024
Q4 2023 $582K $182K -$341K -65.2% 01 Oct 2023 31 Dec 2023 10-Q 19 Jan 2024
Q3 2023 $924K $118K -$38.7K -24.6% 01 Jul 2023 30 Sep 2023 10-K 20 Nov 2023
Q2 2023 $962K $144K +$26.6K +22.6% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024
Q1 2023 $936K $138K +$3.04K +2.26% 01 Jan 2023 31 Mar 2023 10-Q 24 Apr 2024
Q4 2022 $933K $523K +$357K +216% 01 Oct 2022 31 Dec 2022 10-Q 19 Jan 2024
Q3 2022 $575K $157K -$29.4K -15.8% 01 Jul 2022 30 Sep 2022 10-K 20 Nov 2023
Q2 2022 $605K $118K +$18.5K +18.7% 01 Apr 2022 30 Jun 2022 10-Q 25 Jul 2023
Q1 2022 $586K $135K +$94.5K +234% 01 Jan 2022 31 Mar 2022 10-Q 18 Apr 2023
Q4 2021 $492K $165K +$120K +260% 01 Oct 2021 31 Dec 2021 10-Q 19 Jan 2023
Q3 2021 $372K $187K +$140K +300% 01 Jul 2021 30 Sep 2021 10-K 15 Nov 2022
Q2 2021 $232K $99.1K +$55.4K +127% 01 Apr 2021 30 Jun 2021 10-Q 22 Jul 2022
Q1 2021 $177K $40.4K -$26.4K -39.5% 01 Jan 2021 31 Mar 2021 10-Q 21 Apr 2022
Q4 2020 $203K $45.9K -$116K -71.7% 01 Oct 2020 31 Dec 2020 10-Q 20 Jan 2022
Q3 2020 $319K $46.6K -$171K -78.5% 01 Jul 2020 30 Sep 2020 10-K 22 Dec 2021
Q2 2020 $490K $43.8K -$121K -73.5% 01 Apr 2020 30 Jun 2020 10-Q/A 22 Dec 2021
Q1 2020 $611K $66.8K -$191K -74.1% 01 Jan 2020 31 Mar 2020 10-Q 18 Aug 2021
Q4 2019 $803K $162K -$64.1K -28.3% 01 Oct 2019 31 Dec 2019 10-Q 13 Aug 2021
Q3 2019 $867K $217K +$244K 01 Jul 2019 30 Sep 2019 10-K 04 Aug 2021
Q2 2019 $623K $165K -$60.1K -26.7% 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2021
Q1 2019 $683K $258K -$189K -42.3% 01 Jan 2019 31 Mar 2019 10-Q 05 Aug 2021
Q4 2018 $872K $226K -$653K -74.3% 01 Oct 2018 31 Dec 2018 10-Q 05 Aug 2021
Q3 2018 $1.53M -$26.7K -$792K -103% 01 Jul 2018 30 Sep 2018 10-K 21 Jun 2021
Q2 2018 $2.32M $225K -$438K -66% 01 Apr 2018 30 Jun 2018 10-Q 24 Oct 2019
Q1 2018 $2.76M $448K -$211K -32.1% 01 Jan 2018 31 Mar 2018 10-Q 29 Aug 2019
Q4 2017 $2.97M $880K +$346K +64.8% 01 Oct 2017 31 Dec 2017 10-Q 12 Feb 2019
Q3 2017 $2.62M $765K -$11.8K -1.51% 01 Jul 2017 30 Sep 2017 10-K 27 Dec 2018
Q2 2017 $2.63M $663K -$208K -23.9% 01 Apr 2017 30 Jun 2017 10-Q 06 Aug 2018
Q1 2017 $2.84M $659K -$60.7K -8.44% 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018
Q4 2016 $2.9M $534K -$156K -22.6% 01 Oct 2016 31 Dec 2016 10-Q 27 Jan 2017
Q3 2016 $3.06M $777K +$61.8K +8.64% 01 Jul 2016 30 Sep 2016 10-K 21 Dec 2016
Q2 2016 $3M $871K +$249K +40.1% 01 Apr 2016 30 Jun 2016 10-Q 01 Aug 2016
Q1 2016 $2.75M $720K +$98.5K +15.8% 01 Jan 2016 31 Mar 2016 10-Q 29 Apr 2016
Q4 2015 $2.65M $689K +$476K +223% 01 Oct 2015 31 Dec 2015 10-Q 27 Jan 2017
Q3 2015 $2.17M $715K +$522K +271% 01 Jul 2015 30 Sep 2015 10-K 21 Dec 2016
Q2 2015 $1.65M $621K +$464K +294% 01 Apr 2015 30 Jun 2015 10-Q 01 Aug 2016
Q1 2015 $1.19M $621K +$451K +265% 01 Jan 2015 31 Mar 2015 10-Q 29 Apr 2016
Q4 2014 $734K $213K +$27.6K +14.8% 01 Oct 2014 31 Dec 2014 10-Q/A 28 Apr 2017
Q3 2014 $706K $193K 01 Jul 2014 30 Sep 2014 10-K/A 28 Apr 2017
Q2 2014 $158K +$83K +111% 01 Apr 2014 30 Jun 2014 10-Q/A 28 Apr 2017
Q1 2014 $170K +$99.5K +141% 01 Jan 2014 31 Mar 2014 10-Q/A 28 Apr 2017
Q4 2013 $186K 01 Oct 2013 31 Dec 2013 10-Q 04 Feb 2015
Q2 2013 $74.8K 01 Apr 2013 30 Jun 2013 10-Q 07 Aug 2014
Q1 2013 $70.5K 01 Jan 2013 31 Mar 2013 10-Q 05 May 2014

Regen BioPharma Inc Annual Costs and Expenses (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $655K -$269K -29.1% 01 Oct 2023 30 Sep 2024 8-K 29 Nov 2024
2023 $924K +$348K +60.6% 01 Oct 2022 30 Sep 2023 10-K 20 Nov 2023
2022 $575K +$203K +54.6% 01 Oct 2021 30 Sep 2022 10-K 20 Nov 2023
2021 $372K +$52.6K +16.5% 01 Oct 2020 30 Sep 2021 10-K 15 Nov 2022
2020 $319K -$547K -63.2% 01 Oct 2019 30 Sep 2020 10-K 22 Dec 2021
2019 $867K -$659K -43.2% 01 Oct 2018 30 Sep 2019 10-K 04 Aug 2021
2018 $1.53M -$1.1M -41.8% 01 Oct 2017 30 Sep 2018 10-K 21 Jun 2021
2017 $2.62M -$436K -14.3% 01 Oct 2016 30 Sep 2017 10-K 27 Dec 2018
2016 $3.06M +$886K +40.8% 01 Oct 2015 30 Sep 2016 10-K 21 Dec 2016
2015 $2.17M +$1.46M +207% 01 Oct 2014 30 Sep 2015 10-K 21 Dec 2016
2014 $706K +$387K +121% 01 Oct 2013 30 Sep 2014 10-K/A 28 Apr 2017
2013 $320K 01 Oct 2012 30 Sep 2013 10-K 18 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.